Therapeutic Asset Ratings
178 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Pipe-791
Multiple Sclerosis
Contineum Therapeutics
P1
CC
(44)
11c-methylreboxetine
Multiple Sclerosis
Brigham and Women's Hospital
P1/2
CC
(44)
Nbt-Nm108
Multiple Sclerosis
Suhayl Dhib-Jalbut, MD
P1/2
CC
(44)
GADOTERIDOL
Multiple Sclerosis
University of Utah
Early P1
CC
(41)
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril
Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)
P1/2
CC
(41)
Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells
Multiple Sclerosis
Ever Supreme Bio Technology Co., Ltd.
P1/2
CC
(41)
Bendamustine
Multiple Sclerosis
Tr1X, Inc.
P1/2
CC
(41)
Calcium folinate pentahydrate
Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)
P1/2
CC
(41)
Dantrolene
Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)
P1/2
CC
(41)
DEXKETOPROFEN
Multiple Sclerosis
Tokat Gaziosmanpasa University
P1/2
CC
(41)
Mb-Cart2019.1
Multiple Sclerosis
Miltenyi Biomedicine GmbH
P1/2
CC
(41)
METAMIZOLE
Multiple Sclerosis
Tokat Gaziosmanpasa University
P1/2
CC
(41)
NEPENTHE
Multiple Sclerosis
Tokat Gaziosmanpasa University
P1/2
CC
(41)
Pioglitazone
Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)
P1/2
CC
(41)
Pirfenidone
Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)
P1/2
CC
(41)
trx319
Multiple Sclerosis
Tr1X, Inc.
P1/2
CC
(41)
vt7208
Multiple Sclerosis
Vidya Therapeutics Inc
P1/2
CC
(41)
Zofran
Multiple Sclerosis
Tr1X, Inc.
P1/2
CC
(41)
gsk3888130b
Multiple Sclerosis
GlaxoSmithKline
P1
CC
(40)
LISPRO-PH20 COMPONENT RHUPH20
Multiple Sclerosis
Hoffmann-La Roche
P1
CC
(40)
lp-168
Multiple Sclerosis
Guangzhou Lupeng Pharmaceutical Company LTD.
P1
CC
(40)
Lpx-Ti641
Multiple Sclerosis
LAPIX Therapeutics Inc.
P1
CC
(40)
Mtr-601
Multiple Sclerosis
Motric Bio
P1
CC
(40)
[ 18f]3f4ap
Multiple Sclerosis
Massachusetts General Hospital
P1
C
(37)
Allogeneic Adipose-Derived Mesenchymal stromal cells (AD-MSCs)
Multiple Sclerosis
Rennes University Hospital
P1
C
(37)
Showing 101 to 125 of 178 assets
Previous
Page 5 of 8
Next
